.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Medtronic
Fish and Richardson
Cantor Fitzgerald
US Department of Justice
QuintilesIMS
Teva
Moodys
Express Scripts

Generated: November 17, 2017

DrugPatentWatch Database Preview

CLOBETASOL PROPIONATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clobetasol propionate and what is the scope of clobetasol propionate patent protection?

Clobetasol propionate
is the generic ingredient in ten branded drugs marketed by Perrigo Israel, Taro, Ingenus Pharms Llc, Wockhardt, Fougera Pharms, Teligent Pharma Inc, Mylan Pharms Inc, Akorn, Hi Tech Pharma, Actavis Mid Atlantic, Perrigo Co, G And W Labs Inc, Novast Labs Ltd, Glenmark Pharms, Galderma Labs Lp, Galderma Labs, Lupin Ltd, Novel Labs Inc, Tolmar, Zydus Pharms Usa Inc, Teva Pharms Usa, Fougera Pharms Inc, and Paddock Llc, and is included in fifty-three NDAs. There are eleven patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Clobetasol propionate has one hundred and seven patent family members in twenty-six countries.

There are thirteen drug master file entries for clobetasol propionate. Thirty-four suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for CLOBETASOL PROPIONATE

Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE

Tentative approvals for CLOBETASOL PROPIONATE

Applicant Application No. Strength Dosage Form
u► Subscribe0.05%SPRAY;TOPICAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
OLUX E
clobetasol propionate
AEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes► Subscribe► SubscribeY ► Subscribe
Taro
CLOBETASOL PROPIONATE
clobetasol propionate
SOLUTION;TOPICAL075363-001Dec 29, 2000ATRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo Israel
CLOBETASOL PROPIONATE
clobetasol propionate
SHAMPOO;TOPICAL090974-001Aug 9, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CLOBETASOL PROPIONATE
clobetasol propionate
OINTMENT;TOPICAL075057-001Aug 12, 1998AB1RXNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
CLOBETASOL PROPIONATE
clobetasol propionate
CREAM;TOPICAL074139-001Aug 3, 1994AB1RXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CLOBETASOL PROPIONATE
clobetasol propionate
CREAM;TOPICAL075338-001Feb 9, 2001AB1RXNoNo► Subscribe► Subscribe► Subscribe
Perrigo Co
CLOBETASOL PROPIONATE
clobetasol propionate
GEL;TOPICAL075027-001Oct 31, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
CLOBETASOL PROPIONATE
clobetasol propionate
LOTION;TOPICAL209147-001Sep 22, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
CLOBETASOL PROPIONATE
clobetasol propionate
SPRAY;TOPICAL090898-001Jun 16, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
CLOBETASOL PROPIONATE
clobetasol propionate
OINTMENT;TOPICAL074407-001Feb 23, 1996ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms
TEMOVATE
clobetasol propionate
CREAM;TOPICAL019322-001Dec 27, 1985► Subscribe► Subscribe
Mylan Pharms Inc
OLUX
clobetasol propionate
AEROSOL, FOAM;TOPICAL021142-001May 26, 2000► Subscribe► Subscribe
Galderma Labs Lp
CLOBEX
clobetasol propionate
LOTION;TOPICAL021535-001Jul 24, 2003► Subscribe► Subscribe
Fougera Pharms
TEMOVATE
clobetasol propionate
OINTMENT;TOPICAL019323-001Dec 27, 1985► Subscribe► Subscribe
Fougera Pharms
TEMOVATE
clobetasol propionate
SOLUTION;TOPICAL019966-001Feb 22, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: clobetasol propionate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,629,128Vitamin formulation► Subscribe
8,449,867Microemulsion and sub-micron emulsion process and compositions► Subscribe
8,298,515Vitamin formulation► Subscribe
9,492,384Microemulsion and sub-micron emulsion process and compositions► Subscribe
8,263,580Vitamin formulation► Subscribe
5,886,038 Composition and method for treatment of psoriasis► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: clobetasol propionate

Country Document Number Estimated Expiration
Norway20006471► Subscribe
Japan4972553► Subscribe
Japan2002518311► Subscribe
Germany69722546► Subscribe
Germany69937802► Subscribe
Canada2611147► Subscribe
New Zealand508259► Subscribe
World Intellectual Property Organization (WIPO)0015193► Subscribe
Portugal1112062► Subscribe
Portugal832647► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Fish and Richardson
US Army
Express Scripts
Novartis
Queensland Health
McKinsey
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot